First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
Abstract Background Uganda remains one of the countries with the highest burden of TB/HIV. Drug-resistant TB remains a substantial challenge to TB control globally and requires new strategic effective control approaches. Drug resistance usually develops due to inadequate management of TB patients in...
Main Authors: | Jupiter Marina Kabahita, Joel Kabugo, Francis Kakooza, Isa Adam, Ocung Guido, Henry Byabajungu, Joanitah Namutebi, Maria Magdalene Namaganda, Pius Lutaaya, James Otim, Fredrick Elishama Kakembo, Stephen Kanyerezi, Patricia Nabisubi, Ivan Sserwadda, George William Kasule, Hasfah Nakato, Kenneth Musisi, Denis Oola, Moses L. Joloba, Gerald Mboowa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13756-022-01101-2 |
Similar Items
-
Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
by: Rhea Veda Nugraha, et al.
Published: (2021-05-01) -
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023-02-01) -
Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems
by: Daniélle van Staden, et al.
Published: (2022-06-01) -
High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
by: Kanwara Trisakul, et al.
Published: (2022-12-01) -
Systematic Evaluation of Structure-Activity Relationships of the Riminophenazine Class and Discovery of a C2 Pyridylamino Series for the Treatment of Multidrug-Resistant Tuberculosis
by: Haihong Huang, et al.
Published: (2012-04-01)